Approval · Notice of Compliance 3011 · 1998
ONCOSCINT: Notice of Compliance 3011
Issued January 16, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3011
- Date
- January 16, 1998
- Company
- Faulding (Canada) Inc.Montreal, Quebec, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Radiodiagnostic agent, tumor imaging agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONCOSCINT | Not yet assigned | — |
Medicinal ingredients
- SATUMOMAB PENDETIDE 1 MG per VIAL